(Q44232638)

English

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40.

scientific article published on 7 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40. (English)

1 reference

Europe PubMed Central

1 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Bronno van der Holt

2

object named as

B van der Holt

1 reference

Europe PubMed Central

1 December 2017

author name string

A W Rijneveld

1

1 reference

Europe PubMed Central

1 December 2017

S M G J Daenen

3

1 reference

Europe PubMed Central

1 December 2017

B J Biemond

4

1 reference

Europe PubMed Central

1 December 2017

O de Weerdt

5

1 reference

Europe PubMed Central

1 December 2017

P Muus

6

1 reference

Europe PubMed Central

1 December 2017

J Maertens

7

1 reference

Europe PubMed Central

1 December 2017

V Mattijssen

8

1 reference

Europe PubMed Central

1 December 2017

H Demuynck

9

1 reference

Europe PubMed Central

1 December 2017

M C J C Legdeur

10

1 reference

Europe PubMed Central

1 December 2017

P W Wijermans

11

1 reference

Europe PubMed Central

1 December 2017

S Wittebol

12

1 reference

Europe PubMed Central

1 December 2017

F M Spoelstra

13

1 reference

Europe PubMed Central

1 December 2017

A W Dekker

14

1 reference

Europe PubMed Central

1 December 2017

G J Ossenkoppele

15

1 reference

Europe PubMed Central

1 December 2017

R Willemze

16

1 reference

Europe PubMed Central

1 December 2017

J J Cornelissen

17

1 reference

Europe PubMed Central

1 December 2017

Dutch-Belgian HOVON Cooperative group

18

1 reference

Europe PubMed Central

1 December 2017

publication date

7 June 2011

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

25

1 reference

Europe PubMed Central

1 December 2017

11

1 reference

Europe PubMed Central

1 December 2017

1697-1703

1 reference

Europe PubMed Central

1 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2011.141

0 references

Adult acute lymphoblastic leukemia: concepts and strategies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Biology and treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Treatment of adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Progress in the treatment of adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Venous thromboembolism in the hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Thrombosis and acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

21 January 2018

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

7 January 2021

based on heuristic

inferred from DOI database lookup

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of adolescents and young adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.141

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2011.141

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44232638&oldid=2108800526"